Website
News25/Ratings1
News · 26 weeks58-37%
2025-10-262026-04-19
Mix1990d
- Insider12(63%)
- SEC Filings3(16%)
- Earnings2(11%)
- Other2(11%)
Latest news
25 items- INSIDERSEC Form 4 filed by Susi Roger E.4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERSEC Form 4 filed by Susi Roger E.4 - IRADIMED CORP (0001325618) (Issuer)
- PRIRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare ConferenceORLANDO, Fla., April 10, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) today announced that it will participate in the 25th Annual Needham Virtual Healthcare Conference. Iradimed's CFO, Jack Glenn, will host one-on-one meetings with investors at the 25th Annual Needham Virtual Healthcare Conference, which is scheduled to take place from April 13-16, 2026. About IRADIMED CORPORATION IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging ("MRI") compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services. We are the only known provider of a non-magneti
- INSIDERSEC Form 4 filed by Susi Roger E.4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERSEC Form 4 filed by Susi Roger E.4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERSEC Form 4 filed by Susi Roger E.4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERSEC Form 4 filed by Susi Roger E.4 - IRADIMED CORP (0001325618) (Issuer)
- PRIRADIMED CORPORATION to Participate at the 38th Annual Roth ConferenceORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) today announced that it will participate in the 38th Annual Roth Conference. Iradimed's CEO, Roger Susi, and CFO, Jack Glenn, will host one-on-one meetings between company management and investors at the 38th Annual Roth Conference, which will be held at the Ritz-Carlton in Laguna Niguel, CA, on March 22 and 24, 2026. About IRADIMED CORPORATION IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging ("MRI") compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services. We are the onl
- INSIDERCEO, PRESIDENT, CHAIRMAN Susi Roger E. sold $750,475 worth of shares (7,500 units at $100.06) (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERCEO, PRESIDENT, CHAIRMAN Susi Roger E. sold $737,919 worth of shares (7,500 units at $98.39) (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- SECSEC Form 10-K filed by iRadimed Corporation10-K - IRADIMED CORP (0001325618) (Filer)
- INSIDERSEC Form 4 filed by Chief Commercial Officer Chiprin Jeff4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERSEC Form 4 filed by CHIEF FINANCIAL OFFICER Glenn John4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERDirector Allen Monty K sold $100,256 worth of shares (1,000 units at $100.26), decreasing direct ownership by 5% to 21,000 units (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- SECSEC Form 144 filed by iRadimed Corporation144 - IRADIMED CORP (0001325618) (Subject)
- SECiRadimed Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - IRADIMED CORP (0001325618) (Filer)
- PRIRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per ShareReports record revenue of $22.7 million for the fourth quarter of 2025, an increase of $3.3 million, or 17%, compared to the same period in 2024. Reports record GAAP diluted EPS of $0.50 and non-GAAP diluted EPS of $0.54 for the fourth quarter of 2025, which are increases of 25% and 23%, respectively, compared to the same period in 2024. Reports record GAAP diluted EPS of $1.75 and non-GAAP diluted EPS of $1.93 for the full year of 2025, which are increases of 17% and 16%, respectively, compared to the full year of 2024. Declares a regular quarterly cash dividend of $0.20 per share of common stock for the fourth quarter of 2025, payable on March 6, 2026. ORLANDO, Fla., Feb. 10, 2026 (G
- PRIRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026ORLANDO, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2025 fourth quarter and full year financial results before the market opens on Tuesday, February 10, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register-conf.media-server.com/register/BI9eabdb5f5ea54652b0bd15ed7530706e. Once registered, a dial-in number, unique pin, and instructions will be provided to participants.The conference call will also be
- INSIDERCEO, PRESIDENT, CHAIRMAN Susi Roger E. sold $503,255 worth of shares (5,000 units at $100.65) (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERCEO, PRESIDENT, CHAIRMAN Susi Roger E. sold $509,225 worth of shares (5,000 units at $101.84) (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERCEO, PRESIDENT, CHAIRMAN Susi Roger E. sold $487,231 worth of shares (5,000 units at $97.45) (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERCEO, PRESIDENT, CHAIRMAN Susi Roger E. sold $488,417 worth of shares (5,000 units at $97.68) (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERCEO, PRESIDENT, CHAIRMAN Susi Roger E. sold $488,317 worth of shares (5,000 units at $97.66) (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERCEO, PRESIDENT, CHAIRMAN Susi Roger E. sold $483,672 worth of shares (5,000 units at $96.73) (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)
- INSIDERCEO, PRESIDENT, CHAIRMAN Susi Roger E. sold $483,729 worth of shares (5,000 units at $96.75) (SEC Form 4)4 - IRADIMED CORP (0001325618) (Issuer)